John K. Scott Jr., 10% Owner at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), bought 4,000,000 shares at $0.75 ($3.0M) on 2019-06-18, disclosed to the SEC on 2019-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NAVB | BUY | 2019-12-11 | $1000K | — | Filing → |
| NAVB | BUY | 2019-03-25 | $100K | — | Filing → |